Description
ORIGA: Artificial Intelligence Empowering Clinical Research
The ORIGA platform, developed by BOTdesign, leverages Generative AI models created in collaboration with Université Paris Cité to generate artificial patients.
These virtual patients complement real-world cohorts in clinical trials, particularly for fragile or hard-to-recruit populations such as children, pregnant women, and patients with rare diseases or cancer.
By integrating these simulated profiles, ORIGA helps balance underrepresented subgroups and increase the statistical power of Phase II and III clinical trials.
This innovative approach paves the way for more ethical, inclusive, and efficient research, where AI acts as a catalyst for medical discovery while maintaining scientific rigor.
